Back
Goldman Sachs Nasdaq-100 Premium Income ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
61
GPIQ
Goldman Sachs Nasdaq-100 Premium Income ETF
Last Price:
$53.38
Seasonality Move:
-2.79%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$42.83
Seasonality Move:
0.59%
Buy
61
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ)
is a Buy
Is Goldman Sachs Nasdaq-100 Premium Income ETF a Buy, Sell or Hold?
-
The current Goldman Sachs Nasdaq-100 Premium Income ETF [GPIQ] share price is $53.16. The Score for GPIQ is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
GPIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPIQ Stock Price Chart
What is Goldman Sachs Nasdaq-100 Premium Income ETF's stock price today?
-
The Goldman Sachs Nasdaq-100 Premium Income ETF share price today is $53.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIQ is experiencing slight selling pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 54.12 | Buy |
| Chaikin Money Flow: | -295851 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.79 - 53.35) | Buy |
| Bollinger Bands (100): | (50.88 - 53.18) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.47 | Buy |
| Relative Strength Index (14 RSI): | 61.08 | Buy |
| Chaikin Money Flow: | 587345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 39.82) | Buy |
| Bollinger Bands (100): | (17.72 - 34.64) | Buy |
GPIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.62 | Buy |
| 20-day SMA: | 52.88 | Buy |
| 50-day SMA: | 52.81 | Buy |
| 200-day SMA: | 49.39 | Buy |
| 8-day EMA: | 52.73 | Buy |
| 20-day EMA: | 52.75 | Buy |
| 50-day EMA: | 52.57 | Buy |
| 200-day EMA: | 50.54 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.46 | Buy |
| 20-day SMA: | 37.97 | Buy |
| 50-day SMA: | 33.51 | Buy |
| 200-day SMA: | 18.21 | Buy |
| 8-day EMA: | 24.11 | Buy |
| 20-day EMA: | 12.41 | Buy |
| 50-day EMA: | 5.54 | Buy |
| 200-day EMA: | 1.47 | Buy |
Goldman Sachs Nasdaq-100 Premium Income ETF Earnings Growth & GPIQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Goldman Sachs Nasdaq-100 Premium Income ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||